Intra-arterial Chemotherapy for Retinoblastoma: 15-Year Experience

Introduction

Since its introduction in 2008, intra-arterial chemotherapy (IAC) has significantly improved the conservative (eye preserving) management of retinoblastoma (rb), allowing not only the salvage of eyes that would otherwise face enucleation, but also, together with intravitreal chemotherapy, to eradicate the need for external beam irradiation [1]. The success of IAC lies in the achievement of high-dose concentrations of chemotherapy agents directly into the blood vessels that supply the eye, while reducing systemic exposure and complications of intravenous chemotherapy (IVC) such as hospitalizations, port placement, and frequent need for transfusions [2], [3].

Publikationsverlauf

Eingereicht: 01. November 2023

Angenommen: 18. Dezember 2023

Artikel online veröffentlicht:
23. April 2024

• References

• 1 Abramson DH, Shields CL, Munier FL. et al. Treatment of Retinoblastoma in 2015: Agreement and Disagreement. JAMA Ophthalmol 2015; 133: 1341-1347
• 2 Wyse E, Handa JT, Friedman AD. et al. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr Radiol 2016; 46: 1223-1233
• 3 Shields CL, Lally SE, Leahey AM. et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol 2014; 25: 374-385
• 4 Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 2003; 33: 601-607
• 5 Abramson DH, Dunkel IJ, Brodie SE. et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008; 115: 1398-1404 1404.e1
• 6 Klufas MA, Gobin YP, Marr B. et al. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. AJNR Am J Neuroradiol 2012; 33: 1608-1614
• 7 Akkari FG, Stathopoulos C, Puccinelli F. et al. Absorbable gelatin compressed sponge (Gelfoam) embolization of distal external carotid artery branches in intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg 2023;
• 8 Munier FL, Beck-Popovic M, Chantada GL. et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Prog Retin Eye Res 2019; 73: 100764
• 9 Stathopoulos C, Bartolini B, Marie G. et al. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach. Ophthalmology 2021; 128: 754-764
• 10 Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005; 18: 41-53 viii
• 11 Abramson DH, Shields CL, Jabbour P. et al. Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide. Int J Retina Vitreous 2017; 3: 40
• 12 Chen Q, Zhang B, Dong Y. et al. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis. BMC Cancer 2018; 18: 486
• 13 Munier FL, Mosimann P, Puccinelli F. et al. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment. Br J Ophthalmol 2017; 101: 1086-1093
• 14 Gobin YP, Dunkel IJ, Marr BP. et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 2011; 129: 732-737
• 15 Shields CL, Manjandavida FP, Lally SE. et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology 2014; 121: 1453-1460
• 16 Abramson DH, Daniels AB, Marr BP. et al. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. PLoS One 2016; 11: e0146582
• 17 Tuncer S, Sencer S, Kebudi R. et al. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Acta Ophthalmol 2016; 94: e644-e651
• 18 Munier FL, Moulin A, Gaillard MC. et al. Intracameral Chemotherapy for Globe Salvage in Retinoblastoma with Secondary Anterior Chamber Invasion. Ophthalmology 2018; 125: 615-617
• 19 Stathopoulos C, Gaillard MC, Puccinelli F. et al. Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography. Ophthalmic Genet 2018; 39: 242-246
• 20 Feng ZX, Zhao J, Zhang N. et al. Adjuvant Chemotherapy Improves Survival for Children with Massive Choroidal Invasion of Retinoblastoma. Invest Ophthalmol Vis Sci 2023; 64: 27
• 21 Stathopoulos C, Lumbroso-Le Rouic L, Moll AC. et al. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel) 2021; 13: 3392
• 22 Francis JH, Levin AM, Zabor EC. et al. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival. PLoS One 2018; 13: e0197081
• 23 Shields CL, Say EA, Pointdujour-Lim R. et al. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. J Fr Ophtalmol 2015; 38: 542-549
• 24 Francis JH, Abramson DH, Gobin YP. et al. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Ophthalmology 2015; 122: 1016-1022
• 25 De la Huerta I, Seider MI, Hetts SW. et al. Delayed Cerebral Infarction Following Intra-arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmol 2016; 134: 712-714
• 26 Leal-Leal CA, Asencio-Lopez L, Higuera-Calleja J. et al. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye. Rev Invest Clin 2016; 68: 137-142
• 27 Rojanaporn D, Chanthanaphak E, Boonyaopas R. et al. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand. Asia Pac J Ophthalmol (Phila) 2019; 8: 211-217
• 28 Ammanuel S, Alexander MD, Damato B. et al. Improved procedural safety following protocol changes for selective ophthalmic arterial infusion of chemotherapy for treatment of ocular retinoblastoma. Interv Neuroradiol 2018; 24: 345-350
• 29 Dalvin LA, Ancona-Lezama D, Lucio-Alvarez JA. et al. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. Ophthalmology 2018; 125: 1803-1811
• 30 Shields CL, Say EAT, Pefkianaki M. et al. Rhegmatogenous Retinal Detachment after Intraarterial Chemotherapy for Retinoblastoma: The 2016 Founders Award Lecture. Retina 2017; 37: 1441-1450
• 31 Stathopoulos C, Gaillard MC, Moulin A. et al. Intravitreal Anti-Vascular Endothelial Growth Factor for The Management of Neovascularization in Retinoblastoma after Intravenous and/or Intraarterial Chemotherapy: Long-Term Outcomes in a Series of 35 Eyes. Retina 2019; 39: 2273-2282
• 32 Busch MA, Haase A, Alefeld E. et al. Trefoil Family Factor Peptide 1-A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy. Cancers (Basel) 2023; 15: 4828